Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,487,582 Methods for treating pancreatic cancer
The present disclosure is directed to methods of treating pancreatic cancer in subject using cancer with antibodies that specifically bind to progastrin.
US-9,487,581 Anti-CTLA-4 antibody compositions
The present invention provides for novel compositions of anti-CTLA-4 antibodies comprising a chelating agent. Also provided are method of treating diseases and...
US-9,487,580 Human IL-23 antigen binding proteins
Antigen binding proteins that bind to human IL-23 protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same...
US-9,487,579 Methods and compositions for modulation of blood-neural barrier
Methods and compositions for modulating blood-neural barrier (BNB) for the treatment of CNS conditions such as edema, and for increased drug delivery efficacy...
US-9,487,578 Methods and compositions for targeting polyubiquitin
Anti-polyubiquitin monoclonal antibodies, and methods for using the antibodies, are provided.
US-9,487,577 Anti-glucosaminidase passive immunization for Staphylococcus aureus infections
The present invention is directed to a monoclonal antibody that binds specifically to a Staphylococcus aureus glucosaminidase and inhibits in vivo growth of S....
US-9,487,574 Antigen specific multi epitope vaccines
The present invention relates to cancer vaccines composed of the signal peptide domain of tumor associated antigens or proteins. The peptide vaccines of the...
US-9,487,573 Murine anti-NY-ESO-1 T cell receptors
The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for NY-ESO-1. Also provided are related polypeptides,...
US-9,487,572 Non-standard insulin analogues
An insulin analog comprises a B-chain polypeptide containing a cyclohexanylalanine substitution at position B24 and optionally containing additional amino-acid...
US-9,487,571 Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
Provided herein are peptide combinations comprising a GIP agonist peptide and a glucagon antagonist peptide. In some embodiments, the peptide combination is...
US-9,487,570 Glucagon like peptide analogs, composition, and method of use
The present invention relates to novel analogs of glucagon like peptide and compositions that are useful for up-regulating insulin expression in mammals and for...
US-9,487,569 Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
The present invention relates to a novel peptide showing more excellent activities on a glucagon like peptide-1 receptor and a glucagon receptor than native...
US-9,487,568 FGF-2 variants and methods of use thereof
A method of treating an individual (i) having abnormal bone; or (ii) afflicted with a disease or disorder related to normal or abnormal FGF receptors or a...
US-9,487,567 Method for the production of an immunostimulating mucin (MUC1)
The present invention relates to a method for producing or identifying a MUC1 molecule which is able to generate an immune response in humans. The invention...
US-9,487,566 Method for purifying protein
The present invention relates to protein purification. More particularly, a method for directly recovering an objective protein from a protein composition and...
US-9,487,565 Zein composition and methods of production
A high cysteine content zein composition is provided. A method and system for the manufacture of the bioproduct is likewise disclosed herein.
US-9,487,563 Virus-like particles and methods of use
The invention features modified alphavirus or flavivirus virus-like particles (VLPs). The invention provides methods, compositions, and kits featuring the...
US-9,487,562 Stabilized polypeptides as regulators of RAB GTPase function
The present invention provides inventive polypeptides comprising a C terminal RAB binding domain (RabBD) of RAB family interacting proteins (FIPs) stabilized by...
US-9,487,561 Biologically active complex and its preparation
A biologically active complex comprising either a polypeptide having the sequence of a variant of a naturally occurring protein, wherein said polypeptide is at...
US-9,487,560 Angiogenic active lytic peptides
This invention relates to novel synthetic lytic peptide fragments of full-length peptides with the capacity to modulate angiogenic activity in mammals. The...
US-9,487,558 Short bio-active peptides for promoting wound healing
Peptides having four to six amino acid residues are disclosed that possess biological activity. These peptides constitute short fragments of the peptide HB-107...
US-9,487,557 Peptides for management of lactation
The present invention provides novel short peptides that are highly effective in inducing involution in a mammary gland of a lactating mammal and cessation of...
US-9,487,555 Prodrug of an ice inhibitor
This invention describes an ICE inhibitor prodrug (I) having good bioavailability. ##STR00001## Compound I is useful for treating IL-1 mediated diseases such...
US-9,487,554 Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical...
The invention relates to AKR1C3 inhibitors and to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to...
US-9,487,552 Method for preparing an extract of centella asiatica
The invention relates to a method for preparing a refined extract of Centella asiatica comprising a mixture of madecassoside and terminoloside. The method...
US-9,487,551 Small molecule compounds that control mammal-pathogenic nematodes
The present invention relates to methods of modifying nematode behavior using certain isolated modulator compounds. Also disclosed are methods of promoting or...
US-9,487,550 Method of isolating purified RNA with reduced DNA contaminations
The present invention pertains to a method of isolating RNA from a sample comprising RNA, and DNA, comprising: a) adding an acidic denaturing composition...
US-9,487,549 Preparation of lignin
A method for the preparation of lignin from lignocellulosic material by pulping with alcohol, in particular with a C.sub.1-4 alcohol, water and a base, in...
US-9,487,548 Metal complexes comprising diazabenzimidazolocarbene ligands and the use thereof in OLEDs
The present invention relates to metal-carbene complexes comprising a central atom selected from iridium and platinum, and diazabenzimidazolocarbene ligands, to...
US-9,487,547 Cyclic phosphinate derivatives and method of preparing the same
Provided are novel cyclic phosphinate derivatives and a method of preparing the same, and more particularly, cyclic phosphinate derivatives including...
US-9,487,546 Solid forms of tenofovir
The present invention relates to solid forms of tenofovir and methods for preparation, use and isolation of such forms.
US-9,487,545 Fused ring-containing oxazolidinones antibiotics
The present invention relates to a fused ring-containing oxazolidinone compound shown by general formula (I), a pharmaceutically acceptable salt thereof and a...
US-9,487,544 Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
Provided are methods and intermediates for preparing diastereomerically pure phosphoramidate prodrugs of nucleosides of Formulas Ia and Ib: ##STR00001## The...
US-9,487,543 Silicone compound having a radical-polymerizable group and a method for the preparation thereof
A silicon compound that contains a radical-polymerizable group. The silicone compound is liquid at room temperature and has good handling properties, has...
US-9,487,542 Mixed ligand gold(III) complexes and methods thereof
Gold(III) complexes having mixed ligands as anticancer agents. The atom is coordinated by bidentate ligands having diamino functional groups: a ...
US-9,487,541 Fused tricyclic ether carbamates and their use
Tricylic ether carbamates that inhibit HIV proteolytic enzymes and processes for preparing the compounds are describes. Methods of using the disclosed compounds...
US-9,487,540 Compound for inhibiting the growth and proliferation of human liver cancer cells and method for synthesizing it
The compound "2-((4-nitrophenyl)amino)-6,7,8,9-tetrahydro-3H-cyclohepta[4,5]thieno-[2,- 3-d]pyrimidin-4(5H)-one" and method of synthesizing it, wherein the ...
US-9,487,539 Compounds and therapeutic use thereof for protein kinase inhibition
Novel compound having the following formula: ##STR00001## wherein Y is N, O, or S. Also disclosed are a pharmaceutical compositions comprising the same,...
US-9,487,538 Two-carbon linked artemisinin-derived trioxane dimers
Two-carbon linked artemisinin-derived trioxane dimers and methods of their use for treating subjects infected with malaria or other parasitic infectious...
US-9,487,537 Synthesis of isohexide dicarbamates and derivatives thereof
Dicarbamates of the reduction products of 2-hydroxymethyl-5-furfural (HMF) and a method of preparing the same are described. The method involves reacting a...
US-9,487,536 Melampomagnolide B derivatives
The present disclosure provides derivatives of melampomagnolide B (MMB), including carbonates, carbamates, thiocarbamates, ester and amide derivatives of MMB....
US-9,487,535 Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
This invention is directed to asymmetric syntheses of certain spiro-oxindole derivatives, which are useful for the treatment and/or prevention of sodium...
US-9,487,534 Modulators of virus assembly as antiviral agents
In addition to containing and protecting the viral genome, the capsid (protein shell) of hepatitis B virus (HBV) plays critical roles in the viral life cycle...
US-9,487,533 Phosphoinositide 3-kinase inhibitor compounds and methods of use
Compounds of Formulas Ia-d where X is S or O, mor is a morpholine group, and R.sup.3 is a monocyclic heteroaryl group, and including stereoisomers, geometric...
US-9,487,532 Process for preparing oxymorphone, naltrexone, and buprenorphine
Methods are provided which include converting oripavine to other opiates, including converting oripavine to naltrexone, buprenorphine, 14-hydroxymorphinone...
US-9,487,531 Compounds for treatment of pain
The invention is directed to novel compounds, formulations containing said compounds or pharmaceutically acceptable salts thereof which are suitable for...
US-9,487,530 Transient protection of normal cells during chemotherapy
This invention is in the area of improved compounds, compositions and methods of transiently protecting healthy cells, and in particular hematopoietic stem and...
US-9,487,529 Macrocyclic compounds as ALK, FAK and JAK2 inhibitors
The present invention provides compounds of Formula I ##STR00001## or a pharmaceutically acceptable salt forms thereof, wherein R1, R2, R3, R4, R5, A and X...
US-9,487,528 Compounds
Compounds of formula (I), described herein, exhibit human neutrophil elastase inhibitory properties, and are useful for the treatment of diseases and conditions...
US-9,487,527 Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase I
Optionally substituted (5- or 7- amino)-3,4-dihydro-(optionally 4-oxo, 4-thioxo or 4-imino)- 1H-pyrrolo [3,4-d]pyrimidin-2(6H)-ones, Compounds of Formula I,...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.